Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng.
Am J Health Syst Pharm.
1997;54:692-693.
Mortensen SA, Leth A, Agner E, et al. Dose-related decrease of serum coenzyme Q
10
during treatment with HMG-CoA reductase inhibitors.
Mol Aspects Med.
1997;18(suppl):S137-S144.
Ghirlanda G, Oradei A, Manto A, et al. Evidence of plasma CoQ
10
-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study.
J Clin Pharmacol.
1993;33:226-229.
Combs AB, Porter TH, Folkers K. Anticoagulant activity of a naphtoquinone analog of vitamin K and an inhibitor of coenzyme Q
10
-enzyme systems.
Res Commun Chem Pathol Pharmacol.
1976;13:109-114.
Spigset O. Reduced effect of warfarin caused by ubidecarenone [letter].
Lancet.
1994;344:1372-1373.
Lo ACT, Chan K, Yeung JHK, et al. The effects of Danshen
(Salvia miltorrhiza)
on pharmacokinetics and pharmacodynamics of warfarin in rats.
Eur J Drug Metab Pharmacokinet.
1992;17:257-262.
Brinker F.
Herb Contraindications and Drug Interactions: With Appendices Addressing Specific Conditions and Medicines.
2nd ed. Sandy, OR: Eclectic Medical Publications; 1998.
Chan TY. Interaction between warfarin and danshen
(Salvia miltiorrhiza)
.
Ann Pharmacother.
2001;35:501-504.
Shaw D, Leon C, Kolev S, et al. Traditional remedies and food supplements. A 5-year toxicological study (1991-1995).
Drug Saf.
1997;17:342-356.
Page RL II, Lawrence JD. Potentiation of warfarin by dong quai.
Pharmacotherapy.
1999;19:870-876.
Heptinstall S, Groenewegen WA, Spangenberg P, et al. Extracts of feverfew may inhibit platelet behavior via neutralization of sulphydryl groups.
J Pharm Pharmacol.
1987;39:459-465.
Makheja AN, Bailey JM. The active principle in feverfew [letter].
Lancet.
1981;2:1054.
Sumner H, Salan U, Knight DW, et al. Inhibition of 5-lipoxygenase and cyclo-oxygenase in leukocytes by feverfew. Involvement of sesquiterpene lactones and other components.
Biochem Pharmacol.
1992;43:2313-2320.
Groenewegen WA, Heptinstall S. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro.
J Pharm Pharmacol.
1990;42:553-557.
Biggs MJ, Johnson ES, Persaud NP, et al. Platelet aggregation in patients using feverfew for migraine [letter].
Lancet.
1982;2:776.
Gadkari JV, Joshi VD. Effect of ingestion of raw garlic on serum cholesterol level, clotting time and fibrinolytic activity in normal subjects.
J Postgrad Med.
1991;37:128-131.
Burnham BE. Garlic as a possible risk for postoperative bleeding.
Plast Reconstr Surg.
1995;95:213.
Kiesewetter H, Jung F, Jung EM, et al. Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischemic attack.
Eur J Clin Pharmacol.
1993;45:333-336.
[No authors listed]. The effect of essential oil of garlic on hyperlipemia and platelet aggregation—an analysis of 308 cases. Cooperative Group for Essential Oil of Garlic.
J Tradit Chin Med.
1986;6:117-120.
Bordia A. Effect of garlic on human platelet aggregation in vitro.
Atherosclerosis.
1978;30:355-360.
Rose KD, Croissant PD, Parliament CF, et al. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report.
Neurosurgery.
1990;26:880-882.
Sunter WH. Warfarin and garlic.
Pharm J.
1991;246:722.
Backon J. Ginger: inhibition of thromboxane synthetase and stimulation of prostacyclin: relevance for medicine and psychiatry.
Med Hypotheses.
1986;20:271-278.
Srivastava KC. Aqueous extracts of onion, garlic and ginger inhibit platelet aggregation and alter arachidonic acid metabolism.
Biomed Biochim Acta.
1984;43:S335-S346.
Bordia A, Verma SK, Srivastava KC. Effect of ginger (
Zingiber officinale
Rosc.) and fenugreek (
Trigonella foenumgraecum
L.
) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease.
Prostaglandins Leukot Essent Fatty Acids.
1997;56:379-384.
Janssen PL, Meyboom S, van Staveren WA, et al. Consumption of ginger
(Zingiber officinale roscoe)
does not affect ex vivo platelet thromboxane production in humans.
Eur J Clin Nutr.
1996;50:772-774.
Lumb AB. Effect of dried ginger on human platelet function.
Thromb Haemost.
1994;71:110-111.
Chung KF, Dent G, McCusker M, et al. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man.
Lancet.
1987;1:248-251.
Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of
Ginkgo biloba
extract [letter].
N Engl J Med.
1997;336:1108.
Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas with chronic
Ginkgo biloba
ingestion.
Neurology.
1996;46:1775-1776.
Vale S. Subarachnoid hemorrhage associated with
Ginkgo biloba
[letter].
Lancet.
1998;352:36.
Matthews MK Jr. Association of
Ginkgo biloba
with intracerebral hemorrhage.
Neurology.
1998;50:1933-1934.
Taylor JR, Wilt VM. Probable antagonism of warfarin by green tea.
Ann Pharmacother.
1999;33:426-428.
Monostory K, Vereczkey L, Levai F, et al. Ipriflavone as an inhibitor of human cytochrome P450 enzymes.
Br J Pharmacol.
1998;123:605-610.
Shaw D, Leon C, Kolev S, et al. Traditional remedies and food supplements. A 5-year toxicological study (1991-1995).
Drug Saf.
1997;17:342-356.
Arruzazabala ML, Mas R, Molina V, et al. Effect of policosanol on platelet aggregation in type II hypercholesterolemic patients.
Int J Tissue React.
1998;20:119-124.
Arruzazabala ML, Mas R, Molina V, et al. Effect of policosanol on platelet aggregation in type II hypercholesterolemic patients.
Int J Tissue React.
1998;20:119-124.
Arruzazabala ML, Valdes S, Mas R, et al. Effect of policosanol successive dose increases on platelet aggregation in healthy volunteers.
Pharmacol Res.
1996;34:181-185.
Arruzazabala ML, Valdes S, Mas R, et al. Comparative study of policosanol, aspirin and the combination therapy policosanol-aspirin on platelet aggregation in healthy volunteers.
Pharmacol Res.
1997;36:293-297.
Maurer A. Interaction of St. John's wort extract with phenprocoumon.
Eur J Clin Pharmacol.
1999;55:A22.
Jobst KA, McIntyre M, St. George D, et al. Safety of St. John's wort
(Hypericum perforatum)
.
Lancet.
2000:355:575.
Johne A, Brockmuller J, Bauer S, et al. Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort
(Hypericum perforatum)
.
Clin Pharmacol Ther.
1999;66:338-345.
Yue QY, Bergquist C, Gerden B. Safety of St. John's wort [letter].
Lancet.
2000;355:576-577.
Hitzenberger G, Sommer W, Grandt R. Influence of vinpocetine on warfarin-induced inhibition of coagulation.
Int J Clin Pharmacol Ther Toxicol.
1990;28:323-328.
Harris JE. Interaction of dietary factors with oral anticoagulants: review and applications.
J Am Dietet Assoc.
1995;95:580-584.
Harris JE. Interaction of dietary factors with oral anticoagulants: review and applications.
J Am Dietet Assoc.
1995;95:580-584.
Schrogie JJ. Letter: Coagulopathy and fat-soluble vitamins.
JAMA.
1975;232:19.
Rosenthal G. Interaction of ascorbic acid and warfarin [letter].
JAMA.
1971;215:1671.
Smith EC, Skalski RJ, Johnson GC, et al. Interaction of ascorbic acid and warfarin [letter].
JAMA.
1972;221:1166.
White JG, Rao GH, Gerrard JM. Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion.
Am J Pathol.
1977;88:387-402.
Kim JM, White RH. Effect of vitamin E on the anticoagulant response to warfarin.
Am J Cardiol.
1996;77:545-546.
Corrigan J, Marcus FI. Coagulopathy associated with vitamin E ingestion.
JAMA.
1974;230:1300-1301.
Schrogie JJ. Letter: Coagulopathy and fat-soluble vitamins.
JAMA.
1975;232:19.
Pedersen FM, Hamberg O, Hess K, et al. The effect of dietary vitamin K on warfarin-induced anticoagulation.
J Intern Med.
1991;229:517-520.
Chow WH, Chow TC, Tse TM, et al. Anticoagulation instability with life-threatening complication after dietary modification.
Postgrad Med J.
1990;66:855-857.
Weinrobe MC, Montgomery B. Acquired bleeding diathesis in a patient taking PC-SPES [letter].
N Engl J Med.
2001;345:1213-1214.
Lambert JP, Cormier A. Potential interaction between warfarin and boldo-fenugreek.
Pharmacotherapy.
2001;21:509-512.
Su C, Shiao M, Wang C. Potentiation of ganodermic acid S on prostaglandin E(1)-induced cyclic AMP elevation in human platelets.
Thromb Res.
2000;99:135-145.
Engelsen J, Nielsen JD, Winther K. Effect of coenzyme Q10 and
Ginkgo biloba
on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial.
Thromb Haemost.
2002;87:1075-1076.
Kiss B, Karpati E. Mechanism of action of vinpocetine [in Hungarian; English abstract].
Acta Pharm Hung.
1996;66:213-214.
Sovak M, Seligson AL, Konas M, et al. PC-SPES in prostate cancer: an herbal mixture currently containing warfarin and previously diethylstilbestrol and indomethacin. Presented at: 93rd Annual Meeting of the American Association for Cancer Research; April 6-10, 2002; San Francisco, CA.
AbdelFattah W, Hammad T. Chondroitin sulfate and glucosamine: A review of their safety profile.
JANA
2001;3:16-23.
Yuan CS, Wei G, Dey L, et al. American ginseng reduces warfarin's effect in healthy patients.
Ann Intern Med.
2004;141:23-27.
Jiang X, Williams KM, Liauw WS, et al. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Br J Clin Pharmacol.
2004;57:592-599.
Committee on Safety of Medicines. Possible interaction between warfarin and cranberry juice.
Current Problems in Pharmacovigilance.
2003;29:8.
Kohler S, Funk P, Kieser M. Influence of a 7-day treatment with
Ginkgo biloba
special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers.
Blood Coagul Fibrinolysis.
2004;15:303-309.
Kudolo GB, Dorsey S, Blodgett J. Effect of the ingestion of
Ginkgo biloba
extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects.
Thromb Res.
2002;108:151-160.
Bal Dit Sollier C, Caplain H, Drouet L. No alteration in platelet function or coagulation induced by EGb761 in a controlled study.
Clin Lab Haematol.
2003;25:251-253.
Hauser D, Gayowski T, Singh N. Bleeding complications precipitated by unrecognized Gingko biloba use after liver transplantation.
Transpl Int.
2002;15:377-379. Epub 2002 Jun 19.
Fong KC, Kinnear PE. Retrobulbar haemorrhage associated with chronic Gingko biloba ingestion.
Postgrad Med J.
2003;79:531-532.
Cambria-Kiely JA. Effect of soy milk on warfarin efficacy.
Ann Pharmacother.
2002;36:1893-1896.
Jiang X, Williams KM, Liauw WS, et al. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Br J Clin Pharmacol.
2004;57:592-599.
Beatty SJ, Mehta BH, Rodis JL. Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets.
Ann Pharmacother.
2005;39:744-747.
Segal R, Pilote L. Warfarin interaction with Matricaria chamomilla.
CMAJ.
2006;174:1281-1282.
Greenblatt DJ, von Moltke LL, Perloff ES, et al. Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: In vitro and clinical studies.
Clin Pharmacol Ther.
2006;79:125-133.
Kudolo GB, Wang W, Barrientos J, et al. The ingestion of gingko biloba extract (EGb 761) inhibits arachidonic acid-mediated platelet aggregation and thromboxane B
2
production in healthy volunteers.
J Herb Pharmacother.
2005;4:13-26.
Jiang X, Williams KM, Liauw WS, et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Br J Clin Pharmacol.
2005;59:425-432.
Buckley MS, Goff AD, Knapp WE, et al. Fish oil interaction with warfarin.
Ann Pharmacother.
2004;38:50-52.
Jiang X, Williams KM, Liauw WS, et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Br J Clin Pharmacol.
2005;59:425-432.
Li Z, Seeram NP, Carpenter CL, et al. Cranberry does not affect prothrombin time in male subjects on warfarin.
J Am Diet Assoc.
2006;106:2057-2061.
Pham DQ, Pham AQ. Interaction potential between cranberry juice and warfarin.
Am J Health Syst Pharm.
2007;64:490-494.
Welch JM, Forster K. Probable elevation in international normalized ratio from cranberry juice.
J Pharm Technol.
2007;23:104-107.
Lee NJ, Fermo JD. Warfarin and royal jelly interaction.
Pharmacotherapy.
2006;26:583-586.
Rombouts EK, Rosendaal FR, van der Meer FJ. Daily vitamin K supplementation improves anticoagulant stability.
J Thromb Haemost.
2007 Jul 31. [Epub ahead of print]
Last reviewed October 2007 by EBSCO CAM Review Board
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.